Annual report pursuant to Section 13 and 15(d)

Temporary Equity and Stockholders' Deficiency - Schedule of Stock Option Activity (Details)

v3.21.1
Temporary Equity and Stockholders' Deficiency - Schedule of Stock Option Activity (Details)
12 Months Ended
Dec. 31, 2020
USD ($)
$ / shares
shares
Equity [Abstract]  
Number of Options, Outstanding, Beginning | shares 636,750
Number of Options, Granted | shares 115,681
Number of Options, Exercised | shares
Number of Options, Expired | shares (86,187)
Number of Options, Forfeited | shares (39,665)
Number of Options, Outstanding, Ending | shares 626,579
Number of Options, Exercisable, Ending | shares 283,465
Weighted Average Exercise Price, Outstanding, Beginning | $ / shares $ 13.11
Weighted Average Exercise Price, Granted | $ / shares 9.07
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Exercise Price, Expired | $ / shares 17.86
Weighted Average Exercise Price, Forfeited | $ / shares 8.80
Weighted Average Exercise Price, Outstanding, Ending | $ / shares 10.54
Weighted Average Exercise Price, Exercisable, Ending | $ / shares $ 13.70
Weighted Average Remaining Life In Years, Outstanding Ending 3 years 1 month 6 days
Weighted Average Remaining Life In Years, Exercisable Ending 2 years 3 months 19 days
Intrinsic Value, Outstanding Ending | $
Intrinsic Value, Exercisable Ending | $